Lactic acid bacteria—20 years exploring their potential as live vectors for mucosal vaccination

Applied Microbiology and Biotechnology

Volumn 99, Issue 7, 2015, Pages 2967-2977

  Wyszyńska, Agnieszka ^a   Kobierecka, Patrycja ^a   Bardowski, Jacek ^b   Jagusztyn Krynicka, Elżbieta Katarzyna ^a  

^a UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Antigens; DNA vaccine; GEM particles; Immunoprophylaxis; Lactic acid bacteria

Indexed keywords

ANTIGENS; BACTERIA; DRUG DELIVERY; IMMUNIZATION; LACTIC ACID; VACCINES; VIRUSES;

DNA VACCINE; GENETIC MANIPULATIONS; IMMUNOPROPHYLAXIS; LACTIC ACID BACTERIA; LACTOCOCCUS LACTIS; MOLECULAR RESEARCH; THERAPEUTIC DRUG DELIVERY; THERAPEUTIC MOLECULES;

LABORATORIES;

BACTERIAL ANTIGEN; BACTERIAL VECTOR; DNA VACCINE; DRUG CARRIER; LIVE VACCINE; PARASITE ANTIGEN; VIRUS ANTIGEN; IMMUNOLOGICAL ADJUVANT; LACTIC ACID; VACCINE;

ANTIGEN EXPRESSION; BACTERIAL STRAIN; CLONING; DRUG DELIVERY SYSTEM; DRUG EFFICACY; GENETIC ENGINEERING; GENETIC MANIPULATION; HUMAN; IMMUNE SYSTEM; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOCOCCUS; LACTOCOCCUS LACTIS; NONHUMAN; REVIEW; VACCINATION; GENETICS; GRAM POSITIVE BACTERIUM; IMMUNIZATION; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; MUCOSAL DRUG ADMINISTRATION; PROCEDURES;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, MUCOSAL; ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; CLONING, MOLECULAR; GENETIC ENGINEERING; GRAM-POSITIVE BACTERIA; HUMANS; IMMUNIZATION; LACTIC ACID; LACTOBACILLUS; LACTOCOCCUS LACTIS; VACCINES; VACCINES, DNA;

EID: 84925486298     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-015-6498-0     Document Type: Review

References (93)

1. Audouy SA, van Roosmalen ML, Neef J, Kanninga R, Post E, van Deemter M, Metselaar H, van Selm S, Robillard GT, Leenhouts KJ, Hermans PW (2006) Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization. Vaccine 24(26):5434–5441
2. Audouy SA, van Selm S, van Roosmalen ML, Post E, Kanninga R, Neef J, Estevao S, Nieuwenhuis EE, Adrian PV, Leenhouts K, Hermans PW (2007) Development of lactococcal GEM-based pneumococcal vaccines. Vaccine 25(13):2497–2506
3. Benbouziane B, Ribelles P, Aubry C, Martin R, Kharrat P, Riazi A, Langella P, Bermudez-Humaran LG (2013) Development of a stress-inducible controlled expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces. J Biotechnol 168(2):120–129
4. Berlec A, Zadravec P, Jevnikar Z, Strukelj B (2011) Identification of candidate carrier proteins for surface display on Lactococcus lactis by theoretical and experimental analyses of the surface proteome. Appl Environ Microb 77(4):1292–1300
5. Bermudez-Humaran LG, Langella P, Miyoshi A, Gruss A, Guerra RT, Montes de Oca-Luna R, Le Loir Y (2002) Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl Environ Microb 68(2):917–922
6. Bermudez-Humaran LG, Kharrat P, Chatel JM, Langella P (2011) Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact 10 Suppl 1:S4
7. Bolotin A, Wincker P, Mauger S, Jaillon O, Malarme K, Weissenbach J, Ehrlich SD, Sorokin A (2001) The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. Genome Res 11(5):731–753
8. Bosma T, Kanninga R, Neef J, Audouy SA, van Roosmalen ML, Steen A, Buist G, Kok J, Kuipers OP, Robillard G, Leenhouts K (2006) Novel surface display system for proteins on non-genetically modified Gram-positive bacteria. Appl Environ Microb 72(1):880–889
9. Bron PA, Grangette C, Mercenier A, de Vos WM, Kleerebezem M (2004a) Identification of Lactobacillus plantarum genes that are induced in the gastrointestinal tract of mice. J Bacteriol 186(17):5721–5729
10. Bron PA, Hoffer SM, Van S II, De Vos WM, Kleerebezem M (2004b) Selection and characterization of conditionally active promoters in Lactobacillus plantarum, using alanine racemase as a promoter probe. Appl Environ Microb 70(1):310–317
11. Bron PA, Marco M, Hoffer SM, Van Mullekom E, de Vos WM, Kleerebezem M (2004c) Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract. J Bacteriol 186(23):7829–7835
12. Buist G, Karsens H, Nauta A, van Sinderen D, Venema G, Kok J (1997) Autolysis of Lactococcus lactis caused by induced overproduction of its major autolysin, AcmA. Appl Environ Microb 63(7):2722–2728
13. Buist G, Steen A, Kok J, Kuipers OP (2008) LysM, a widely distributed protein motif for binding to (peptido)glycans. Mol Microbiol 68(4):838–847
14. Call EK, Klaenhammer TR (2013) Relevance and application of sortase and sortase-dependent proteins in lactic acid bacteria. Front Microbiol 4:73
15. Chatel JM, Pothelune L, Ah-Leung S, Corthier G, Wal JM, Langella P (2008) In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells. Gene Ther 15(16):1184–1190
16. Cortes-Perez NG, Bermudez-Humaran LG, Le Loir Y, Rodriguez-Padilla C, Gruss A, Saucedo-Cardenas O, Langella P, Montes-de-Oca-Luna R (2003) Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein. FEMS Microbiol Lett 229(1):37–42
17. Cortes-Perez NG, Lefevre F, Corthier G, Adel-Patient K, Langella P, Bermudez-Humaran LG (2007) Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria. Vaccine 25(36):6581–6588
18. Corthesy B, Boris S, Isler P, Grangette C, Mercenier A (2005) Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J Infect Dis 192(8):1441–1449
19. Daniel C, Roussel Y, Kleerebezem M, Pot B (2011) Recombinant lactic acid bacteria as mucosal biotherapeutic agents. Trends Biotechnol 29(10):499–508
20. Daudel D, Weidinger G, Spreng S (2007) Use of attenuated bacteria as delivery vectors for DNA vaccines. Expert Rev Vaccines 6(1):97–110
21. de Azevedo M, Karczewski J, Lefevre F, Azevedo V, Miyoshi A, Wells JM, Langella P, Chatel JM (2012) In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A. BMC Microbiol 12:299
22. de Vos WM (1987) Gene cloning and expression in lactic streptococci. FEMS Microbiol Rev 46:281–295
23. de Vos WM (2011) Systems solutions by lactic acid bacteria: from paradigms to practice. Microb Cell Fact 10 Suppl 1:S2
24. Dieye Y, Usai S, Clier F, Gruss A, Piard JC (2001) Design of a protein-targeting system for lactic acid bacteria. J Bacteriol 183(14):4157–4166
25. Duong T, Miller MJ, Barrangou R, Azcarate-Peril MA, Klaenhammer TR (2011) Construction of vectors for inducible and constitutive gene expression in Lactobacillus. Microb Biotechnol 4(3):357–367
26. FAO/WHO (2001) Health and nutritional properties of probiotics in food including powder milk with live lacti acid bacteria. Cordoba, Argentina. http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf
27. Ferreira DM, Miyaji EN, Oliveira ML, Darrieux M, Areas AP, Ho PL, Leite LC (2006) DNA vaccines expressing pneumococcal surface protein a (PspA) elicit protection levels comparable to recombinant protein. J Med Microbiol 55(Pt 4):375–378
28. Fontana L, Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S, Gil A (2013) Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr 109(Suppl 2):S35–50
29. Grangette C, Muller-Alouf H, Goudercourt D, Geoffroy MC, Turneer M, Mercenier A (2001) Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect Immun 69(3):1547–1553
30. Grangette C, Muller-Alouf H, Geoffroy M, Goudercourt D, Turneer M, Mercenier A (2002) Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence. Vaccine 20(27–28):3304–3309
31. Grangette C, Muller-Alouf H, Hols P, Goudercourt D, Delcour J, Turneer M, Mercenier A (2004) Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria. Infect Immun 72(5):2731–2737
32. Guimaraes VD, Innocentin S, Lefevre F, Azevedo V, Wal JM, Langella P, Chatel JM (2006) Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Appl Environ Microb 72(11):7091–7097
33. Hanniffy SB, Carter AT, Hitchin E, Wells JM (2007) Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J Infect Dis 195(2):185–193
34. Hu S, Kong J, Kong W, Guo T, Ji M (2010) Characterization of a novel LysM domain from Lactobacillus fermentum bacteriophage endolysin and its use as an anchor to display heterologous proteins on the surfaces of lactic acid bacteria. Appl Environ Microb 76(8):2410–2418
35. Hugentobler F, Di Roberto RB, Gillard J, Cousineau B (2012a) Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection. Vaccine 30(39):5726–5732
36. Hugentobler F, Yam KK, Gillard J, Mahbuba R, Olivier M, Cousineau B (2012b) Immunization against Leishmania major infection using LACK- and IL-12-expressing Lactococcus lactis induces delay in footpad swelling. PLoS One 7(2):e30945
37. Innocentin S, Guimaraes V, Miyoshi A, Azevedo V, Langella P, Chatel JM, Lefevre F (2009) Lactococcus lactis expressing either Staphylococcus aureus fibronectin-binding protein A or Listeria monocytogenes internalin a can efficiently internalize and deliver DNA in human epithelial cells. Appl Environ Microb 75(14):4870–4878
38. Isolauri E, Salminen S, Ouwehand AC (2004) Microbial–gut interactions in health and disease. Prob Best Prac Res Clin Gastro 18(2):299–313
39. Iwaki M, Okahashi N, Takahashi I, Kanamoto T, Sugita-Konishi Y, Aibara K, Koga T (1990) Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene. Infect Immun 58(9):2929–2934
40. Kajikawa A, Nordone SK, Zhang L, Stoeker LL, LaVoy AS, Klaenhammer TR, Dean GA (2011) Dissimilar properties of two recombinant Lactobacillus acidophilus strains displaying Salmonella FliC with different anchoring motifs. Appl Environ Microb 77(18):6587–6596
41. Kajikawa A, Zhang L, Long J, Nordone S, Stoeker L, LaVoy A, Bumgardner S, Klaenhammer T, Dean G (2012) Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clin Vaccine Immunol 19(9):1374–1381. doi:10.1128/CVI. 00049-12
42. Kim TW, Igimi S, Kajikawa A, Kim HY (2008) Display of heterologous proteins on the surface of Lactococcus lactis using the H and W domain of PrtB from Lactobacillus delburueckii subsp. bulgaricus as an anchoring matrix. J Appl Microbiol 104(6):1636–1643
43. Kobierecka P, Wyszyńska A, Maruszewska M, Wojtania A, Żylińska J, Bardowski J, Jagusztyn-Krynicka EK (2015) Lactic acid bacteria as a surface display platform for Campylobacter jejuni antigens. J Mol Microbiol Biotechnol 25(1):1–10. doi:10.1159/000368780
44. Kok J, van der Vossen JM, Venema G (1984) Construction of plasmid cloning vectors for lactic streptococci which also replicate in Bacillus subtilis and Escherichia coli. Appl Environ Microb 48(4):726–731
45. Le Loir Y, Gruss A, Ehrlich SD, Langella P (1998) A nine-residue synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis. J Bacteriol 180(7):1895–1903
46. Lee MH, Roussel Y, Wilks M, Tabaqchali S (2001) Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 19(28–29):3927–3935
47. Li X, Xing Y, Guo L, Lv X, Song H, Xi T (2014) Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice. Pathog Dis 72(1):78–86
48. Linares DM, Kok J, Poolman B (2010) Genome sequences of Lactococcus lactis MG1363 (revised) and NZ9000 and comparative physiological studies. J Bacteriol 192(21):5806–5812
49. Llull D, Poquet I (2004) New expression system tightly controlled by zinc availability in Lactococcus lactis. Appl Environ Microb 70(9):5398–5406
50. Macho Fernandez E, Pot B, Grangette C (2011) Beneficial effect of probiotics in IBD: are peptidogycan and NOD2 the molecular key effectors? Gut Microbes 2(5):280–286
51. Madsen SM, Arnau J, Vrang A, Givskov M, Israelsen H (1999) Molecular characterization of the pH-inducible and growth phase-dependent promoter P170 of Lactococcus lactis. Mol Microbiol 32(1):75–87
52. Maidin MS, Song AA, Jalilsood T, Sieo CC, Yusoff K, Rahim RA (2014) Construction of a novel inducible expression vector for Lactococcus lactis M4 and Lactobacillus plantarum Pa21. Plasmid 74:32–38
53. Marelli B, Perez AR, Banchio C, de Mendoza D, Magni C (2011) Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice. J Virol Methods 175(1):28–37
54. Mierau I, Kleerebezem M (2005) 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biot 68(6):705–717
55. Mohamadzadeh M, Duong T, Sandwick SJ, Hoover T, Klaenhammer TR (2009) Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci U S A 106(11):4331–4336
56. Mohamadzadeh M, Durmaz E, Zadeh M, Pakanati KC, Gramarossa M, Cohran V, Klaenhammer TR (2010) Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine. Future Microbiol 5(8):1289–1296
57. Moorthy G, Ramasamy R (2007) Mucosal immunisation of mice with malaria protein on lactic acid bacterial cell walls. Vaccine 25(18):3636–3645
58. Morello E, Bermudez-Humaran LG, Llull D, Sole V, Miraglio N, Langella P, Poquet I (2008) Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion. J Mol Microbiol Biotechnol 14(1–3):48–58
59. Mu D, Montalban-Lopez M, Masuda Y, Kuipers OP (2013) Zirex: a novel zinc-regulated expression system for Lactococcus lactis. Appl Environ Microb 79(14):4503–4508
60. Oliveira ML, Areas AP, Campos IB, Monedero V, Perez-Martinez G, Miyaji EN, Leite LC, Aires KA, Lee Ho P (2006) Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A. Microbes Infect 8(4):1016–1024
61. Perez CA, Eichwald C, Burrone O, Mendoza D (2005) Rotavirus vp7 antigen produced by Lactococcus lactis induces neutralizing antibodies in mice. J Appl Microbiol 99(5):1158–1164
62. Pontes D, Innocentin S, Del Carmen S, Almeida JF, Leblanc JG, de Moreno De Leblanc A, Blugeon S, Cherbuy C, Lefevre F, Azevedo V, Miyoshi A, Langella P, Chatel JM (2012) Production of fibronectin binding protein A at the surface of Lactococcus lactis increases plasmid transfer in vitro and in vivo. PLoS One 7(9):e44892
63. Radziwill-Bienkowska JM, Zochowska D, Bardowski J, Mercier-Bonin M, Kowalczyk M (2014) Lactococcus lactis IBB477 presenting adhesive and muco-adhesive properties as a candidate carrier strain for oral vaccination against influenza virus. Acta Biochim Pol 61(3):603–607
64. Raha AR, Varma NR, Yusoff K, Ross E, Foo HL (2005) Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Appl Microbiol Biot 68(1):75–81
65. Ramasamy R, Yasawardena S, Zomer A, Venema G, Kok J, Leenhouts K (2006) Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations. Vaccine 24(18):3900–3908
66. Ramirez K, Ditamo Y, Rodriguez L, Picking WL, van Roosmalen ML, Leenhouts K, Pasetti MF (2010) Neonatal mucosal immunization with a non-living, non-genetically modified Lactococcus lactis vaccine carrier induces systemic and local Th1-type immunity and protects against lethal bacterial infection. Mucosal Immunol 3(2):159–171
67. Reveneau N, Geoffroy MC, Locht C, Chagnaud P, Mercenier A (2002) Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine 20(13–14):1769–1777
68. Ribeiro LA, Azevedo V, Le Loir Y, Oliveira SC, Dieye Y, Piard JC, Gruss A, Langella P (2002) Production and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosis. Appl Environ Microb 68(2):910–916
69. Saluja V, Amorij JP, van Roosmalen ML, Leenhouts K, Huckriede A, Hinrichs WL, Frijlink HW (2010a) Intranasal delivery of influenza subunit vaccine formulated with GEM particles as an adjuvant. AAPS J 12(2):109–116
70. Saluja V, Visser MR, Ter Veer W, van Roosmalen ML, Leenhouts K, Hinrichs WL, Huckriede A, Frijlink HW (2010b) Influenza antigen-sparing by immune stimulation with Gram-positive enhancer matrix (GEM) particles. Vaccine 28(50):7963–7969
71. Schoen C, Loeffler DI, Frentzen A, Pilgrim S, Goebel W, Stritzker J (2008) Listeria monocytogenes as novel carrier system for the development of live vaccines. Int J Med Microbiol 298(1–2):45–58
72. Shareck J, Choi Y, Lee B, Miguez CB (2004) Cloning vectors based on cryptic plasmids isolated from lactic acid bacteria: their characteristics and potential applications in biotechnology. Crit Rev Biotechnol 24(4):155–208
73. Simon D, Chopin A (1988) Construction of a vector plasmid family and its use for molecular cloning in Streptococcus lactis. Biochimie 70(4):559–566
74. Steen A, Buist G, Leenhouts KJ, El Khattabi M, Grijpstra F, Zomer AL, Venema G, Kuipers OP, Kok J (2003) Cell wall attachment of a widely distributed peptidoglycan binding domain is hindered by cell wall constituents. J Biol Chem 278(26):23874–23881
75. Steidler L, Wells JM, Raeymaekers A, Vandekerckhove J, Fiers W, Remaut E (1995) Secretion of biologically active murine interleukin-2 by Lactococcus lactis subsp. lactis. Appl Environ Microb 61(4):1627–1629
76. Steidler L, Robinson K, Chamberlain L, Schofield KM, Remaut E, Le Page RW, Wells JM (1998a) Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect Immun 66(7):3183–3189
77. Steidler L, Viaene J, Fiers W, Remaut E (1998b) Functional display of a heterologous protein on the surface of Lactococcus lactis by means of the cell wall anchor of Staphylococcus aureus protein A. Appl Environ Microb 64(1):342–345
78. Stoeker L, Nordone S, Gunderson S, Zhang L, Kajikawa A, LaVoy A, Miller M, Klaenhammer TR, Dean GA (2011) Assessment of Lactobacillus gasseri as a candidate oral vaccine vector. Clin Vaccine Immunol 18(11):1834–1844
79. Szatraj K, Szczepankowska AK, Saczynska V, Florys K, Gromadzka B, Lepek K, Plucienniczak G, Szewczyk B, Zagorski-Ostoja W, Bardowski J (2014) Expression of avian influenza haemagglutinin (H5) and chicken interleukin 2 (chIL-2) under control of the ptcB promoter in Lactococcus lactis. Acta Biochim Pol 61(3):609–614
80. Turner MS, Hafner LM, Walsh T, Giffard PM (2004) Identification and characterization of the novel LysM domain-containing surface protein Sep from Lactobacillus fermentum BR11 and its use as a peptide fusion partner in Lactobacillus and Lactococcus. Appl Environ Microb 70(6):3673–3680
81. Vadesilho CF, Ferreira DM, Moreno AT, Chavez-Olortegui C, Machado de Avila RA, Oliveira ML, Ho PL, Miyaji EN (2012) Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae. Microb pathogenesis 53(5–6):243–249
82. van Asseldonk M, Rutten G, Oteman M, Siezen RJ, de Vos WM, Simons G (1990) Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363. Gene 95(1):155–160
83. van Roosmalen ML, Kanninga R, El Khattabi M, Neef J, Audouy S, Bosma T, Kuipers A, Post E, Steen A, Kok J, Buist G, Kuipers OP, Robillard G, Leenhouts K (2006) Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria. Methods 38(2):144–149
84. Villena J, Medina M, Raya R, Alvarez S (2008) Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. Can J Microbiol 54(10):845–853
85. Villena J, Medina M, Racedo S, Alvarez S (2010) Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis. J Microbiol Immunol Infect 43(1):1–10
86. Villena J, Oliveira ML, Ferreira PC, Salva S, Alvarez S (2011) Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges. Int Immunopharmacol 11(11):1633–1645
87. Wegmann U, O’Connell-Motherway M, Zomer A, Buist G, Shearman C, Canchaya C, Ventura M, Goesmann A, Gasson MJ, Kuipers OP, van Sinderen D, Kok J (2007) Complete genome sequence of the prototype lactic acid bacterium Lactococcus lactis subsp. cremoris MG1363. J Bacteriol 189(8):3256–3270
88. Wells JM, Mercenier A (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6(5):349–362
89. Wieczorek AS, Martin VJ (2010) Engineering the cell surface display of cohesins for assembly of cellulosome-inspired enzyme complexes on Lactococcus lactis. Microb Cell Fact 9:69
90. Wyszynska A, Raczko A, Lis M, Jagusztyn-Krynicka EK (2004) Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene elicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter. Vaccine 22(11–12):1379–1389
91. Xu W, Huang M, Zhang Y, Yi X, Dong W, Gao X, Jia C (2011) Novel surface display system for heterogonous proteins on Lactobacillus plantarum. Lett Appl Microbiol 53(6):641–648
92. Zadravec P, Mavric A, Bogovic Matijasic B, Strukelj B, Berlec A (2014) Engineering BmpA as a carrier for surface display of IgG-binding domain on Lactococcus lactis. Protein Eng Des Sel 27(1):21–27
93. Zeuthen LH, Fink LN, Frokiaer H (2008) Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells. Immunology 124(4):489–502